NCT00667134View on ClinicalTrials.gov

Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

February 29, 2012

Conditions
Systemic Sclerosis
Trial Locations (1)

48103

University of Michigan Medical School, Ann Arbor

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Michigan

OTHER

NCT00667134 - Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis | Biotech Hunter | Biotech Hunter